Caxton Associates (New York)’s iShares MSCI Emerging Markets ETF EEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-286,200
Closed -$11.5M 516
2022
Q2
$11.5M Buy
+286,200
New +$12M 1.12% 13
2021
Q3
Sell
-340,000
Closed -$18.8M 479
2021
Q2
$18.8M Buy
+340,000
New +$18.5M 2.06% 11
2018
Q4
Sell
-300,000
Closed -$12.9M 335
2018
Q3
$12.9M Sell
300,000
-5,565,000
-95% -$240M 0.89% 22
2018
Q2
$254M Buy
5,865,000
+2,765,000
+89% +$128M 12.83% 1
2018
Q1
$150M Buy
3,100,000
+2,600,000
+520% +$127M 7.64% 2
2017
Q4
$23.6M Sell
500,000
-4,650,000
-90% -$215M 1.16% 21
2017
Q3
$231M Hold
5,150,000
8.24% 2
2017
Q2
$213M Sell
5,150,000
-195,350,000
-97% -$7.95B 8.22% 1
2017
Q1
$7.9B Buy
+200,500,000
New +$7.61B 30.63% 1
2016
Q4
Sell
-950,000
Closed -$35.6M 229
2016
Q3
$35.6M Buy
+950,000
New +$34.7M 1.2% 14
2016
Q2
Sell
-750,000
Closed -$25.7M 187
2016
Q1
$25.7M Buy
+750,000
New +$23.2M 1.81% 8

Other funds holding EEM

Caxton Associates (New York)'s EEM Position: Q4 2023 in Review

Caxton Associates (New York) sold out of iShares MSCI Emerging Markets ETF (EEM) in Q4 2023, closing a stake of 72,490 shares — an estimated $2.75M sold.

Caxton Associates (New York) first reported a position in EEM in Q2 2013 and held it in 25 quarters. The position peaked at $153M in Q3 2018. 1,313 funds tracked by Wall St. Rank hold EEM as of Q4 2023.

  • Caxton Associates (New York) reported no remaining iShares MSCI Emerging Markets ETF position as of Q4 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 72,490 iShares MSCI Emerging Markets ETF shares in Q4 2023, an estimated $2.75M.
  • Caxton Associates (New York) first reported a position in iShares MSCI Emerging Markets ETF in Q2 2013 and held it in 25 quarters.
  • Caxton Associates (New York)'s iShares MSCI Emerging Markets ETF position peaked at $153M in Q3 2018.
  • 1,313 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ETF as of Q4 2023.

Based on Caxton Associates (New York)'s 13F filing for Q4 2023, filed 14 Feb 2024.